The precise role of nitric oxide (NO) in hypertension is still not fully understood, although this vasodilator system represents the main counterbalance of major pressor systems. The aim of our study was to determine the contributions of superoxide anions, the renin-angiotensin system (RAS), the sympathetic nervous system (SNS) and NO to the maintenance of blood pressure (BP) in Prague hereditary hypertriglyceridaemic (HTG) rats with genetic hypertension. Conscious chronically cannulated rats were subjected to the consecutive blockade of the RAS (losartan, 10 mg/kg), the SNS (pentolinium, 5 mg/kg) and NO synthase [N ω -nitro-L-arginine (L-NAME), 30 mg/kg]. Some additional rats were pretreated with tempol (a membrane-permeable mimetic of superoxide dismutase). A subsequent genetic study in HTGiLewis F 2 hybrid rats (n l 284) was designed to reveal potential associations of particular BP components with baseline BP. The progenitor study indicated that BP elevation was more pronounced in male than female HTG rats (as compared with normotensive Lewis controls). Higher BP in HTG rats was due to the increased residual BP (measured after combined RAS and SNS blockade) and the augmentation of BP responses to tempol or losartan. In contrast, BP responses to pentolinium or L-NAME were similar in all experimental groups. It should, however, be noted that the baseline BP of progenitor animals was correlated positively with both residual BP and the magnitude of the BP response to pentolinium, but not with BP response to L-NAME. Similarly, the baseline BP of F 2 hybrid rats was positively associated with residual BP, the BP response to pentolinium and the relative SNS contribution to BP maintenance [expressed as a percentage of baseline mean arterial pressure (MAP) values], as well as with the ratio of BP changes elicited by ganglion blockade and NO synthase inhibition (∆MAP pentolinium /∆MAP L-NAME ratio), reflecting the balance of main vasopressor and vasodepressor systems. Thus our studies, performed in progenitor and F 2 hybrid rats, revealed that changes in BP induced by L-NAME do not keep pace with the progressive augmentation of pentolinium-induced changes in BP occurring over a wide range of increasing BP. The altered balance between enhanced SNS-dependent vasoconstriction and unchanged NO-dependent vasodilation (' relative NO deficiency ' in rats with high BP) might result in BP elevation in this form of genetic hypertension.
INTRODUCTION
An impaired balance between vasoconstrictor and vasodilator systems affecting the tone of resistance vessels is one of the characteristic features of hypertension. Since the discovery of endothelium-derived relaxing factor and its identification as nitric oxide (NO), considerable research has been carried out into impaired vascular relaxation in both human essential hypertension and genetic hypertension of the rat [1, 2] .
In precontracted arteries of spontaneously hypertensive rats (SHRs), there is a characteristic attenuation of the endothelium-dependent response to various vasodilatory agents, such as acetylcholine [3] . This endothelial dysfunction appears gradually during the development of hypertension [4] [5] [6] . The endothelial counterbalance of noradrenaline-induced contractions decreases with aging and hypertension [7, 8] . Although a substantial part of this alteration can be ascribed to the enhanced secretion of cyclo-oxygenase-dependent endothelium-derived constricting factor [4, 6, 9] , a role for attenuated NO production cannot be excluded [8, 10, 11] . In fact, NO-dependent vasodilation is reduced with aging, but it is not impaired by hypertension [12, 13] . Thus overall NO production and its role in the control of blood pressure (BP) are usually not attenuated in immature or adult SHRs [14] [15] [16] . Nevertheless, increased superoxide production further reduces the availability of formed NO [17, 18] , contributing to the impairment of vascular relaxation in genetically hypertensive animals.
To elucidate the contribution of NO to actual BP maintenance, Minami et al. [19] investigated the balance between vascular NO and major pressor systems [namely the sympathetic nervous system (SNS)] in conscious normotensive and spontaneously hypertensive animals. They reported that the vasodilatory effects of vascular NO were similar in both SHRs and Wistar-Kyoto rats, whereas the increased pressor effects of the NO synthase inhibitor N ω -nitro-L-arginine methyl ester (L-NAME) in SHRs were ascribed to the enhanced action of hypertrophied vascular amplifier. This is in accordance with previous observations by Yamazaki et al. [14] , who described augmentation of the pressor effects of NO synthase inhibition during the progression of hypertension in SHRs.
Recently we described [20] that a moderately upregulated NO system in salt hypertensive Dahl rats was unable to counterbalance effectively the hyperactivity of the SNS. In these animals, the acute administration of tempol (a membrane-permeable mimetic of superoxide dismutase) caused not only a pronounced decrease in BP, but also a substantial augmentation of the rise in BP that occurred after acute NO synthase inhibition. The observed predominance of sympathetic vasoconstriction over NO-dependent vasodilation seemed to be related to enhanced NO inactivation due to augmented superoxide anion formation in salt hypertensive animals. Our genetic study in salt-loaded Dahl F # hybrids [21] confirmed the importance of sympathetic hyperactivity and structural changes to resistance vessels [reflected by increased residual BP recorded after combined renin-angiotensin system (RAS) and SNS blockade] for the maintenance of high BP in salt hypertensive rats. It should be pointed out that both a progenitor study [20] and an F # hybrid study [21] indicated a relative NO deficiency in salt hypertensive Dahl rats. In both cases there was no absolute attenuation of NO formation and\or vasoactive NO action to below control levels, but the activity of NO system was not increased sufficiently to match appropriately the enhanced sympathetic vasoconstriction.
The aim of our present study was to evaluate the role of major vasoconstrictor and vasodilator systems in BP control in Prague hereditary hypertriglyceridaemic (HTG) rats and their F # hybrids. HTG rats, which represent a model of genetic hypertension and hypertriglyceridaemia [22] , were selected from Wistar rats for elevated plasma triacylglycerols (triglycerides) [23] . This form of experimental hypertension with dyslipidaemia is, however, not accompanied by obesity [24] or hypercholesterolaemia [25, 26] . Our progenitor study focused on the participation of superoxide anions, the SNS, the RAS and NO in the maintenance of BP in hypertensive HTG and normotensive Lewis rats of both sexes. Our subsequent study in F # hybrids was designed to reveal presumed associations of particular BP components with baseline BP level and\or plasma lipid abnormalities, since our previous studies in HTGiLewis F # hybrids demonstrated positive relationships between plasma triacylglycerols, BP [27] and erythrocyte sodium transport [28] .
METHODS

Animals
The experiments were carried out in two inbred strainshypertensive HTG rats and normotensive Lewis rats (used as controls). Animals from our own colony were housed under standard laboratory conditions (temperature 23p1 mC, 12 h light\dark cycle), were fed on standard laboratory chow ST-1 (Velaz, Prague, Czech Republic) and drank tap water ad libitum. All procedures and experimental protocols, which were approved by the local Ethical Committee of the Institute of Physiology AS CR, conformed with the European Convention on Animal Protection.
The participation of major vasoactive systems (RAS, SNS and NO) and superoxide anions was determined first in both progenitor strains using 36 HTG and 38 Lewis rats of either sex, aged 5 months. Thereafter the roles of the major vasoactive systems were studied in 284 F # hybrids of both sexes obtained from two reciprocal crosses of normotensive Lewis and hypertensive HTG Sympathetic nervous system and NO in genetic hypertension 
Experimental protocol
On the day before BP determination, serum triacylglycerols and total cholesterol levels were determined using commercially available kits (Bio-La-Test ; Lachema, Brno, Czech Republic) in blood obtained from the tail vessels of non-fasted animals under light ether anaesthesia. Thereafter polyethylene catheters were inserted into the left carotid artery and jugular vein and exteriorized in the interscapular region. BP was recorded in conscious animals after a 24 h recovery period using a Statham pressure transducer and a multichannel HewlettPackard recorder. The system was calibrated before each recording and validated carefully in terms of signal dampening in the catheters. BP was always recorded in three animals simultaneously. To eliminate the influence of circadian variation in BP, the measurements were always done between 08.00 and 12.00 hours.
The experimental procedure is shown in Figure 1 . Baseline values of mean arterial pressure (MAP) were monitored in conscious animals for 30 min. Thereafter an intravenous bolus of losartan (DuPont-Merck, Wilmington, MA, U.S.A. ; 10 mg\kg body weight) was injected in order to block angiotensin AT " receptors. After a further 10 min, ganglion blockade was induced by pentolinium (Sigma, St. Louis, MO, U.S.A. ; 5 mg\kg), which was followed by a rapid fall in BP. When low residual BP values were temporarily stabilized (Figure 1 ), L-NAME (Sigma ; 30 mg\kg) was given (about 5 min after pentolinium), and restoration of BP was monitored for the next 20 min. All drugs were given intravenously in a volume of 1 ml\kg.
Repeated administration of the above drugs in various phases of our experimental protocol demonstrated that the doses used elicited almost maximal BP effects which persisted during the entire experiment (results not shown). This was also true for pentolinium, because a second application during the rise in BP elicited by L-NAME administration did not influence BP. Further HTG and Lewis male rats (n l 5 each) were used to demonstrate the reversibility of BP effects induced by L-NAME (30 mg\kg) by an intravenous bolus of L-arginine (300 mg\kg).
Additional HTG and Lewis rats of both sexes were pretreated with tempol (a membrane-permeable mimetic of superoxide dismutase) [20, 29] , which was given as an intravenous bolus (25 mg\kg) 15 min before the consecutive blockade of other vasoactive systems.
In each rat, baseline MAP values as well as MAP values reached after the administration of particular blockers were used for the calculation of MAP responses to losartan, pentolinium and L-NAME administration. Both the absolute and relative contributions of each vasoactive system studied to BP maintenance were estimated in all animals. Relative contributions were expressed as a percentage of baseline MAP values.
Statistical analysis
Results were expressed as meanspS.E.M. Statistical differences were evaluated by Student's t test (in the case of a simple comparison) or by one-way ANOVA followed by the least significant difference test (in the case of multiple comparisons). Linear univariate and multivariate correlation analysis was used to test the relationships between BP, plasma lipids and other phenotypes of interest.
RESULTS
Progenitor study
Adult hypertensive HTG rats had higher plasma triacylglycerol levels but lower levels of plasma total cholesterol than normotensive Lewis rats, the latter difference being significant in females only. Compared with Lewis animals, the BP elevation was more pronounced in male than in female HTG rats, but pulse pressure was augmented in HTG rats of both sexes (Table 1 ). Figure 1 shows that a moderate difference in BP between HTG and Lewis rats was preserved after the Table 1 Body weight, plasma lipids, baseline BP and BP response to the blockade of the RAS (losartan), the SNS (pentolinium) and NO synthase (L-NAME) in 5-month-old HTG and Lewis rats of both sexes Data are meanspS.E.M. The relative contributions of RAS, SNS and NO represent ∆MAP losartan , ∆MAP pentolinium and ∆MAP L-NAME expressed as a percentage of baseline MAP. Significance of differences : *P 0.05, **P 0.01 compared with Lewis rats of the same sex ; †P 0.05, † †P 0.01 compared with male rats of the same genotype.
Males Females
Parameter HTG (n l 10) Lewis (n l 9) HTG (n l 9) Lewis (n l 12) (Table 1 ). In both strains there was a similar rapid pronounced fall in MAP after pentolinium injection. It should be noted that male HTG rats had significantly higher values of residual MAP (measured after combined blockade of RAS and SNS), but the magnitude of the rise in MAP occurring after L-NAME administration was again similar in HTG and Lewis rats. The two strains did not differ significantly in the relative contributions of particular vasoactive systems to BP maintenance, except for a tendency for HTG males to have attenuated NO participation in BP control (Table 1) . Nevertheless, the absence of significant strain differences in the magnitude of SNS-and NO-dependent BP components does not exclude an important role for such systems in BP elevation. The analysis of a combined set of progenitor animals (n l 40) revealed that baseline MAP was correlated positively not only with the residual MAP level (r l 0.554, P 0.001), but also with the magnitude of the pentolinium-induced MAP fall (r l 0.614, P 0.0001). In contrast, there was no significant relationship between baseline MAP and the magnitude of the rise in MAP elicited by L-NAME administration (r lk0.049). Consequently, baseline MAP was correlated positively with the ratio of MAP changes induced by pentolinium and L-NAME (∆MAP pentolinium \ Figure 2 Relationship between effects on MAP elicited by acute L-NAME treatment and subsequent L-arginine administration in HTG and Lewis male rats subjected to previous combined RAS and SNS blockade , HTG rats ; , Lewis rats. Drug concentrations were as follows : losartan, 10 mg/kg ; pentolinium, 5 mg/kg ; L-NAME, 30 mg/kg ; L-arginine, 300 mg/kg. The inset shows overall MAP changes in both groups of rats (meanspS.E.M.).
∆MAP L-NAME ratio ; r l 0.391, P 0.02) and negatively with the relative contribution of NO to BP maintenance (expressed as a percentage of baseline MAP) (r lk0.458, P 0.005). These data indicate the predominance of sympathetic vasoconstriction over NO-dependent vasodilation in animals with elevated BP. Sympathetic nervous system and NO in genetic hypertension Figure 2 shows that almost the full extent of the rise in BP induced by L-NAME in rats subjected to prior RAS and SNS blockade was temporarily eliminated by the acute administration of L-arginine (300 mg\kg), which caused a fall in BP that lasted for about 2 min. There was an excellent correlation (over a wide range of individual values) between the rise in BP elicited by L-NAME and the fall in BP induced by L-arginine in animals with NO synthase inhibition. Figure 3 (B) indicates that a considerable part of the difference in BP between the two rat strains could be ascribed to the hypertensive effects of superoxide anions. The reduction in their levels by acute tempol administration lowered BP significantly in hypertensive HTG rats, but not in normotensive Lewis rats. This was true in both male and female animals. There was a highly significant correlation between baseline BP and tempol-induced BP changes ( Figure 3C ). However, tempol administration did not modify significantly the subsequent BP response of HTG rats to L-NAME administration (results not shown).
Genetic study
The presence of sex-dependent differences in particular phenotypes between male and female F # hybrids (Table 2) might represent a problem for the analysis of our data. Compared with males, females were characterized by higher plasma levels of total cholesterol, greater pulse pressure and lower diastolic BP. Furthermore, their residual MAP and final MAP values were lower, even if they did not differ in baseline MAP from F # males. The fall in MAP after pentolinium was similar in both sexes, but losartan elicited a slightly greater decrease in MAP in females. On the other hand, the rise in MAP induced by L-NAME was significantly attenuated in F # females compared with F # males. Consequently, final MAP surpassed significantly baseline MAP in F # males only, whereas the ratio between MAP changes induced by pentolinium and L-NAME was greater in F # females ( Table 2 ). The presentation of results obtained by correlation analysis (Table 3) was therefore limited to those relationships for which similar findings were obtained not only in male and female F # hybrids analysed separately, but also in the whole F # cohort consisting of 284 animals. Fortunately, this was the case for nearly all interesting relationships between baseline BP and effects on BP exerted by particular vasoactive systems.
Baseline BP was positively related to both residual BP and BP response to pentolinium, but not to BP responses to losartan or L-NAME administration (Figure 4 ). This was true for both male and female F # hybrids (Table 3) , the respective regression lines being almost identical. A highly significant positive relationship between baseline MAP and the relative contribution of the SNS to BP maintenance (pentolinium-induced MAP changes expressed as a percentage of baseline MAP) suggests sympathetic hyperactivity in hypertensive rats. On the other hand, there was no significant relationship between baseline MAP and the relative contribution of the RAS to BP maintenance. The inverse association of baseline MAP with the relative contribution of NO to BP maintenance (L-NAME-induced BP response expressed as a percentage of baseline MAP) merely reflects the fact that the absolute BP changes induced by L-NAME were independent of the baseline BP level. One of the most interesting findings was the highly significant positive correlation between baseline MAP and the ratio of MAP changes induced by pentolinium and L-NAME (Table 3) , which suggests the importance of sympathetic hyperactivity combined with relative NO deficiency in hypertensive animals.
Final MAP (recorded after the blockade of all three vasoactive systems), which tended to correlate positively with baseline MAP (significantly in F # females), was Data are r coefficients. Significance : ***P 0.001, **P 0.01, *P 0.05 ; NS, not significant. highly dependent on the residual MAP, and especially on the L-NAME-induced MAP changes (Table 3 ). However, it should be noted that the magnitude of MAP changes induced by L-NAME was completely independent of residual MAP (r l 0.099). Plasma triacylglycerols were positively associated with baseline BP (r l 0.166, n l 284, P 0.005), especially in F # females (r l 0.208, n l 139, P 0.02). Plasma triacylglycerols were correlated negatively with the relative contribution of the RAS to BP maintenance (r lk0.171, P 0.05, r lk0.170, P 0.05 and r lk0.174, P 0.002 for males, females and whole F # population respectively). On the other hand, there were no significant associations with total plasma cholesterol level, except for the MAP response to L-NAME (∆MAP L-NAME ) in females (r l 0.250, n l 139, P 0.001). This was also confirmed by multiple regression analysis of ∆MAP L-NAME with plasma triacylglycerols, plasma chol-Sympathetic nervous system and NO in genetic hypertension 
DISCUSSION
Our study has revealed that the difference in BP between progenitor strains (hypertensive HTG and normotensive Lewis rats) can be ascribed to the elevation in residual BP (probably due to structural alterations to resistance vessels), an augmented hypertensive influence of superoxide anions and an increased RAS-dependent BP component in HTG animals. Although no major differences in the participation of the SNS and NO in BP maintenance were demonstrated between HTG and Lewis rats, the baseline BP of progenitor animals was directly proportional to the magnitude of the pentoliniuminduced fall in BP (SNS-dependent BP component), whereas it had no significant relationship with the magnitude of the L-NAME-induced rise in BP (NOdependent BP component). It is obvious that, in animals with increased BP, NO-dependent vasodilation was not able to counterbalance the enhanced sympathetic vasoconstriction, suggesting a relative NO deficiency in HTG rats. This is in accordance with our previous findings in salt hypertensive Dahl rats [20] .
Our genetic study in HTGiLewis F # hybrid animals indicated the importance of both residual BP and the SNS-dependent BP component in the determination of the baseline BP level. Not only absolute, but also relative, values (expressed as a percentage of baseline MAP) of pentolinium-induced changes in MAP were correlated positively with baseline MAP. This confirms an important role for vasoconstrictor SNS effects in the actual BP maintenance over a wide range of BP values, with a major augmentation of sympathetic activity in hypertensive animals. It is evident from the slopes of particular relationships depicted in Figure 4 that the SNS is responsible for the major part of the elevation in BP in this segregating population, whereas the remaining part may be ascribed to structural alterations to resistance vessels and\or to the activity of residual pressor systems. The observation that sympathetic hyperactivity is one of the major pathogenetic factors in this form of genetic hypertension is in good agreement with the results of genetic studies carried out in segregating populations derived from SHRs [30, 31] .
To our knowledge, this F # study represents a rare attempt to evaluate the contribution of NO to BP maintenance in segregating populations by means of measuring the corresponding phenotypes. Our genetic study revealed that the absolute L-NAME-induced BP elevation did not rise with increasing baseline BP. A comparison of the pentolinium-and L-NAME-induced BP changes in Figure 4 indicates that only SNSdependent vasoconstriction (and not NO-dependent vasodilation) was proportional to baseline BP. It is evident that the activity of the NO system was not high enough to match SNS hyperactivity in hypertensive F # animals. This can be documented by the highly significant positive association of baseline BP with the ratio of BP changes induced by pentolinium and L-NAME. The same observations were also made in salt-loaded F # hybrids derived from salt-sensitive and salt-resistant Dahl rats [21] . It remains to be determined whether the enhanced inactivation of NO caused by exaggerated superoxide production, which has been described in Dahl rats [20, 32] , SHRs [18, 33, 34] and aged Sprague-Dawleyderived hypertriglyceridaemic rats [35] , could lead to these changes in SNS\NO balance. Nevertheless, enhanced superoxide production might explain why the upregulation of NO pathway, together with a relative inability of NO to stimulate cGMP formation and vasodilation, was observed in mesenteric resistance vessels of adult SHRs [34] .
DNA samples obtained from the present F # hybrids facilitated a co-operative pharmacogenetic study in this hypertensive model. Several significant quantitative trait loci for hypertension and hypertriglyceridaemia were disclosed on rat chromosomes 1, 3 and 4. One of these loci, which is located on chromosome 1, was linked to the BP response occurring after acute inhibition of NO synthase and to the final BP level achieved after L-NAME administration [36, 37] .
In conclusion, our present study, performed using the Prague strain of genetically hypertensive rats with hypertriglyceridaemia and their F # hybrids, indicates an altered balance between SNS-dependent vasoconstriction and NO-dependent vasodilation, favouring BP elevation. A relative NO deficiency (the attenuation of the NOdependent BP component compared with the magnitude of the SNS-dependent BP component) was demonstrated with the progression of hypertension in both progenitor and F # rats.
